The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Protective effects of the mechanistic target of rapamycin against excess iron and ferroptosis in cardiomyocytes
Open accessAbstract
Clinical studies have suggested that myocardial iron is a risk factor for left ventricular remodeling in patients after myocardial infarction. Ferroptosis has recently been reported as a mechanism of iron-dependent nonapoptotic cell death. However, ferroptosis in the heart is not well understood. Mechanistic target of rapamycin (mTOR) protects the heart against pathological stimuli such as ischemia. To define the role of cardiac mTOR on cell survival in iron-mediated cell death, we examined cardiomyocyte (CM) cell viability under excess iron and ferroptosis conditions. Adult mouse CMs were isolated from cardiac-specific mTOR transgenic mice, cardiac-specific mTOR knockout mice, or control mice. CMs were treated with ferric iron [Fe(III)]-citrate, erastin, a class 1 ferroptosis inducer, or Ras-selective lethal 3 (RSL3), a class 2 ferroptosis inducer. Live/dead cell viability assays revealed that Fe(III)-citrate, erastin, and RSL3 induced cell death. Cotreatment with ferrostatin-1, a ferroptosis inhibitor, inhibited cell death in all conditions. mTOR overexpression suppressed Fe(III)-citrate, erastin, and RSL3-induced cell death, whereas mTOR deletion exaggerated cell death in these conditions. 2',7'-Dichlorodihydrofluorescein diacetate measurement of reactive oxygen species (ROS) production showed that erastin-induced ROS production was significantly lower in mTOR transgenic versus control CMs. These findings suggest that ferroptosis is a significant type of cell death in CMs and that mTOR plays an important role in protecting CMs against excess iron and ferroptosis, at least in part, by regulating ROS production. Understanding the effects of mTOR in preventing iron-mediated cell death will provide a new therapy for patients with myocardial infarction. NEW & NOTEWORTHY Ferroptosis has recently been reported as a new form of iron-dependent nonapoptotic cell death. However, ferroptosis in the heart is not well characterized. Using cultured adult mouse cardiomyocytes, we demonstrated that the mechanistic target of rapamycin plays an important role in protecting cardiomyocytes against excess iron and ferroptosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Regulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Kim, J., Kundu, M., Viollet, B., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2152 · Cited by 7,227 · cited 2×
“mTOR inhibits autophagy mainly through phosphorylation of Unc-51-like kinase (ULK) (28).”
BackgroundFerroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398 · cited 2×
“On the other hand, a previous report (24) by another group showed that an autophagy inhibitor did not suppress erastin-induced ferroptotic cell death.”
BackgroundAdvances in metal-induced oxidative stress and human disease
Jomova, K., & Valko, M. (2011) · Toxicology · doi:10.1016/j.tox.2011.03.001 · Cited by 3,207
Ferroptosis: Death by Lipid Peroxidation
Yang, W. S., & Stockwell, B. R. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.10.014 · Cited by 3,088
Dixon, S. J., Patel, D. N., Welsch, M., Skouta, R., Lee, E. D., Hayano, M., Thomas, A. G., Gleason, C. E., Tatonetti, N. P., Slusher, B. S., et al. (2014) · eLife · doi:10.7554/elife.02523 · Cited by 2,088
Glutaminolysis and transferrin regulate ferroptosis
Gao, M., Monian, P., Quadri, N., Ramasamy, R., & Jiang, X. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.06.011 · Cited by 2,069 · cited 2×
“A recent study (21) using ex vivo perfused hearts suggested that ferroptosis is a key toward the pathogenesis of ischemia-reperfusion (I/R) injury and that deferoxamine (DFO), a chelator, protects the heart against ex vivo I/R injury.”
BackgroundFerroptosis is an autophagic cell death process
Gao, M., Monian, P., Pan, Q., Zhang, W., Xiang, J., & Jiang, X. (2016) · Cell Research · doi:10.1038/cr.2016.95 · Cited by 1,899
RAS–RAF–MEK-dependent oxidative cell death involving voltage-dependent anion channels
Yagoda, N., von Rechenberg, M., Zaganjor, E., Bauer, A. J., Yang, W. S., Fridman, D. J., Wolpaw, A. J., Smukste, I., Peltier, J. M., Boniface, J. J., et al. (2007) · Nature · doi:10.1038/nature05859 · Cited by 1,631
Caspase structure, proteolytic substrates, and function during apoptotic cell death
Nicholson, D. (1999) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400598 · Cited by 1,543
Cao, J. Y., & Dixon, S. J. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2194-1 · Cited by 1,515 · cited 5×
“Chelators such as 2,2-bipyridyl effectively inhibit erastin- and RSL3-induced ferroptosis (10, 15).”
BackgroundInfluentialFerrostatins Inhibit Oxidative Lipid Damage and Cell Death in Diverse Disease Models
Skouta, R., Dixon, S. J., Wang, J., Dunn, D. E., Orman, M., Shimada, K., Rosenberg, P. A., Lo, D. C., Weinberg, J. M., Linkermann, A., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja411006a · Cited by 1,146 · cited 1×
“Ferrostatin-1 inhibits lipid peroxidation but not mitochondrial ROS formation or lysosomal membrane permeability (42).”
BackgroundRedox- and non-redox-metal-induced formation of free radicals and their role in human disease
Valko, M., Jomova, K., Rhodes, C. J., Kuča, K., & Musílek, K. (2016) · Archives of Toxicology · doi:10.1007/s00204-015-1579-5 · Cited by 1,022
Autophagy: assays and artifacts
Barth, S., Glick, D., & Macleod, K. F. (2010) · The Journal of Pathology · doi:10.1002/path.2694 · Cited by 793
Characterization of ferroptosis in murine models of hemochromatosis
Wang, H., An, P., Xie, E., Wu, Q., Fang, X., Gao, H., Zhang, Z., Li, Y., Wang, X., Zhang, J., et al. (2017) · Hepatology · doi:10.1002/hep.29117 · Cited by 660
Non-transferrin bound iron: a key role in iron overload and iron toxicity
Brissot, P., Ropert, M., Le Lan, C., & Loréal, O. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.07.014 · Cited by 654 · cited 1×
“However, several tissues, including hepatocytes and cardiomyocytes, take up nontransferrin-bound iron (NTBI) without TfR1 regulation (8).”
BackgroundIron Overload in Human Disease
Fleming, R. E., & Ponka, P. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1004967 · Cited by 587
Betz, C., Stracka, D., Prescianotto-Baschong, C., Frieden, M., Demaurex, N., & Hall, M. N. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1302455110 · Cited by 538 · cited 1×
“Although the role of mTOR in regulated mPTP-dependent necrosis in CMs is not well characterized, previous reports have demonstrated that mTOR is located in the mitochondrial outer membrane and is directly or indirectly bound to key proteins in cell survival and metabolism, such as VDAC1 and Bcl-xL (6, 40).”
BackgroundFerritins: Dynamic Management of Biological Iron and Oxygen Chemistry
Liu, X., & Theil, E. C. (2005) · Accounts of Chemical Research · doi:10.1021/ar0302336 · Cited by 514
Gangloff, Y.-G., Mueller, M., Dann, S. G., Svoboda, P., Sticker, M., Spetz, J.-F., Um, S. H., Brown, E. J., Cereghini, S., Thomas, G., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9508-9516.2004 · Cited by 485 · cited 1×
“These mice contain loxP sites that flank exons 1–5 of the mTOR gene (19).”
BackgroundDirect control of mitochondrial function by mTOR
Ramanathan, A., & Schreiber, S. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912074106 · Cited by 365
Dixon, S. J. (2017) · Immunological Reviews · doi:10.1111/imr.12533 · Cited by 314
Emerging roles for lipids in non-apoptotic cell death
Magtanong, L., Ko, P. J., & Dixon, S. J. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2016.25 · Cited by 260
Ferroportin‐mediated mobilization of ferritin iron precedes ferritin degradation by the proteasome
De Domenico, I., Vaughn, M. B., Li, L., Bagley, D., Musci, G., Ward, D. M., & Kaplan, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601409 · Cited by 235 · cited 1×
“Since the cellular level of iron regulates ferritin synthesis and degradation (13, 33), these findings suggest that iron overload occurs in CMs around the infarct zone in post-MI hearts.”
BackgroundCardiac ferroportin regulates cellular iron homeostasis and is important for cardiac function
Lakhal-Littleton, S., Wolna, M., Carr, C. A., Miller, J. J. J., Christian, H. C., Ball, V., Santos, A., Diaz, R., Biggs, D., Stillion, R., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422373112 · Cited by 234
Phosphoinositide-3 Kinase Signaling in Cardiac Hypertrophy and Heart Failure
Aoyagi, T., & Matsui, T. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211796390976 · Cited by 213
Self-citationmTOR regulates cellular iron homeostasis through tristetraprolin
Bayeva, M., Khechaduri, A., Puig, S., Chang, H.-C., Patial, S., Blackshear, P. J., & Ardehali, H. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.10.001 · Cited by 197
Bulluck, H., Rosmini, S., Abdel-Gadir, A., White, S. K., Bhuva, A. N., Treibel, T. A., Fontana, M., Ramlall, M., Hamarneh, A., Sirker, A., et al. (2016) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.116.004940 · Cited by 182
Regulated Necrotic Cell Death: The Passive Aggressive Side of Bax and Bak
Karch, J. M., & Molkentin, J. D. (2015) · Circulation Research · doi:10.1161/circresaha.116.305421 · Cited by 180
Physiological Roles of the Permeability Transition Pore
Brenner, C., & Moulin, M. (2012) · Circulation Research · doi:10.1161/circresaha.112.265942 · Cited by 178
Yu, X., & Long, Y. C. (2016) · Scientific Reports · doi:10.1038/srep30033 · Cited by 170
Nature of non-transferrin-bound iron: studies on iron citrate complexes and thalassemic sera
Evans, R. W., Rafique, R., Zarea, A., Rapisarda, C., Cammack, R., Evans, P. J., Porter, J. B., & Hider, R. C. (2007) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-007-0297-8 · Cited by 165
Cardiac mTOR protects the heart against ischemia-reperfusion injury
Aoyagi, T., Kusakari, Y., Xiao, C.-Y., Inouye, B. T., Takahashi, M., Scherrer‐Crosbie, M., Rosenzweig, A., Hara, K., & Matsui, T. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00241.2012 · Cited by 152
Self-citationReduction in mitochondrial iron alleviates cardiac damage during injury
Chang, H., Wu, R., Shang, M., Sato, T., Chen, C., Shapiro, J. S., Liu, T., Thakur, A., Sawicki, K. T., Prasad, S. V. N., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201505748 · Cited by 144
Kim, J. Y., Kanai, Y., Chairoungdua, A., Ho, S., Matsuo, H., Kim, D. K., Inatomi, J., Sawa, H., Ida, Y., & Endou, H. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00338-8 · Cited by 143
Yang, K.-T., Chang, W.-L., Yang, P.-C., Chien, C.-L., Lai, M.-S., Su, M., & Wu, M.-L. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401813 · Cited by 142
Song, X., Kusakari, Y., Xiao, C., Kinsella, S., Rosenberg, M. A., Scherrer‐Crosbie, M., Hara, K., Rosenzweig, A., & Matsui, T. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00338.2010 · Cited by 142
Self-citationPalmitate-induced apoptosis in neonatal cardiomyocytes is not dependent on the generation of ROS
Hickson-Bick, D. L. M., Sparagna, G. C., Buja, L. M., & McMillin, J. B. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00726.2001 · Cited by 109
Schriewer, J. M., Peek, C. B., Bass, J. T., & Schumacker, P. T. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000159 · Cited by 104
Chan, W., Taylor, A. J., Ellims, A., Lefkovits, L., Wong, C. Y., Kingwell, B. A., Natoli, A., Croft, K. D., Mori, T. A., Kaye, D. M., et al. (2012) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.111.966226 · Cited by 102
Sirolimus Interferes with Iron Homeostasis in Renal Transplant Recipients
Maiorano, A., Stallone, G., Schena, A., Infante, B., Pontrelli, P., Schena, F. P., & Grandaliano, G. (2006) · Transplantation · doi:10.1097/01.tp.0000235545.49391.1b · Cited by 77
The mTOR Signaling Pathway in Myocardial Dysfunction in Type 2 Diabetes Mellitus
Suhara, T., Baba, Y., Shimada, B. K., Higa, J. K., & Matsui, T. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0865-4 · Cited by 72
Self-citationOmiya, S., Hikoso, S., Imanishi, Y., Saito, A., Yamaguchi, O., Takeda, T., Mizote, I., Oka, T., Taneike, M., Nakano, Y., et al. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.09.714 · Cited by 71
Isolation, Culture, and Functional Analysis of Adult Mouse Cardiomyocytes
Liao, R., & Jain, M. (2007) · Methods in molecular medicine · doi:10.1007/978-1-59745-571-8_16 · Cited by 63
Aoyagi, T., Higa, J. K., Aoyagi, H., Yorichika, N., Shimada, B. K., & Matsui, T. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00008.2015 · Cited by 40
Self-citationGuan, P., & Wang, N. (2014) · Nutrition · doi:10.1016/j.nut.2013.12.016 · Cited by 39
Przybylowski, P., Malyszko, J. S., Macdougall, I. C., & Malyszko, J. (2013) · Transplantation Proceedings · doi:10.1016/j.transproceed.2012.02.040 · Cited by 26 · cited 1×
“Clinical studies have shown that chronic treatment with mTOR inhibitors such as sirolimus are associated with the development of microcytic anemia, suggesting that mTOR plays a key role in iron homeostasis (35, 39).”
Background
Cited by
Ferroptosis: molecular mechanisms and health implications
Tang, D., Chen, X., Kang, R., & Kroemer, G. (2021) · Cell Research · doi:10.1038/s41422-020-00441-1 · Cited by 4,256
NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis
Dodson, M., Castro-Portuguez, R., & Zhang, D. D. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101107 · Cited by 2,435
Ferroptosis: machinery and regulation
Chen, X., Li, J., Kang, R., Klionsky, D. J., & Tang, D. (2021) · Autophagy · doi:10.1080/15548627.2020.1810918 · Cited by 2,099
Yi, J., Zhu, J., Wu, J., Thompson, C. B., & Jiang, X. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2017152117 · Cited by 974
Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease
Del Re, D. P., Amgalan, D., Linkermann, A., Liu, Q., & Kitsis, R. N. (2019) · Physiological Reviews · doi:10.1152/physrev.00022.2018 · Cited by 961
Metadata
- Authors
- Baba, Y., Higa, J. K., Shimada, B. K., Horiuchi, K. M., Suhara, T., Kobayashi, M., Woo, J. D., Aoyagi, H., Marh, K. S., Kitaoka, H., & Matsui, T.
- Venue
- American Journal of Physiology-Heart and Circulatory Physiology
- Publisher
- American Physiological Society
- Published
- 2018-03
- Volume
- 314
- Issue
- 3
- Pages
- H659-H668
- ISSN
- 0363-6135 (ISSN-L)
- 1522-1539
- OpenAlex
- W2767876404
- Cited by
- 347
- References
- 49
- FWCI
- 11.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.